CGC
Price
$0.87
Change
-$0.16 (-15.53%)
Updated
Sep 20, 6:59 PM EST
49 days until earnings call
CRON
Price
$2.18
Change
-$0.03 (-1.36%)
Updated
Sep 20, 6:59 PM EST
54 days until earnings call

CGC vs CRON ᐉ Comparison: Which is Better to Invest?

Header iconCGC vs CRON Comparison
Open Charts CGC vs CRONBanner chart's image
Canopy Growth
Price$0.87
Change-$0.16 (-15.53%)
Volume$62.63M
CapitalizationN/A
Cronos Group
Price$2.18
Change-$0.03 (-1.36%)
Volume$1.52M
CapitalizationN/A
View a ticker or compare two or three
CGC vs CRON Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
CGC vs. CRON commentary
Sep 21, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a Sell and CRON is a Hold.

COMPARISON
Comparison
Sep 21, 2023
Stock price -- (CGC: $0.87 vs. CRON: $2.18)
Brand notoriety: CGC: Notable vs. CRON: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CGC: 156% vs. CRON: 94%
Market capitalization -- CGC: $749.66M vs. CRON: $859.5M
CGC [@Pharmaceuticals: Other] is valued at $749.66M. CRON’s [@Pharmaceuticals: Other] market capitalization is $859.5M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $83.54B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileCRON’s FA Score has 1 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • CRON’s FA Score: 1 green, 4 red.
According to our system of comparison, CRON is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 6 TA indicator(s) are bullish while CRON’s TA Score has 6 bullish TA indicator(s).

  • CGC’s TA Score: 6 bullish, 3 bearish.
  • CRON’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CGC is a better buy in the short-term than CRON.

Price Growth

CGC (@Pharmaceuticals: Other) experienced а -24.83% price change this week, while CRON (@Pharmaceuticals: Other) price change was -10.66% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.15%. For the same industry, the average monthly price growth was +15.15%, and the average quarterly price growth was +9.07%.

Reported Earning Dates

CGC is expected to report earnings on Nov 09, 2023.

CRON is expected to report earnings on Nov 14, 2023.

Industries' Descriptions

@Pharmaceuticals: Other (+1.15% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
A.I.dvisor published
a Summary for CGC with price predictions.
OPEN
A.I.dvisor published
a Summary for CRON with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CRON($859M) has a higher market cap than CGC($750M). CRON YTD gains are higher at: -14.173 vs. CGC (-62.251). CRON has higher annual earnings (EBITDA): -114.52M vs. CGC (-1.05B). CRON has more cash in the bank: 841M vs. CGC (571M). CRON has less debt than CGC: CRON (3.22M) vs CGC (1.14B). CGC has higher revenues than CRON: CGC (406M) vs CRON (86.1M).
CGCCRONCGC / CRON
Capitalization750M859M87%
EBITDA-1.05B-114.52M920%
Gain YTD-62.251-14.173439%
P/E RatioN/AN/A-
Revenue406M86.1M472%
Total Cash571M841M68%
Total Debt1.14B3.22M35,205%
FUNDAMENTALS RATINGS
CGC vs CRON: Fundamental Ratings
CGC
CRON
OUTLOOK RATING
1..100
1217
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
70
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9892
PRICE GROWTH RATING
1..100
3541
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRON's Valuation (70) in the Pharmaceuticals Other industry is in the same range as CGC (92) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew similarly to CGC’s over the last 12 months.

CRON's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew similarly to CGC’s over the last 12 months.

CRON's SMR Rating (92) in the Pharmaceuticals Other industry is in the same range as CGC (98) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew similarly to CGC’s over the last 12 months.

CGC's Price Growth Rating (35) in the Agricultural Commodities Or Milling industry is in the same range as CRON (41) in the Pharmaceuticals Other industry. This means that CGC’s stock grew similarly to CRON’s over the last 12 months.

CRON's P/E Growth Rating (1) in the Pharmaceuticals Other industry is significantly better than the same rating for CGC (100) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew significantly faster than CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCCRON
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 7 days ago
73%
Bullish Trend 8 days ago
75%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
REAIX22.840.06
+0.26%
American Century Real Estate I
ICEUX37.80-0.04
-0.11%
MainStay Epoch International Choice I
EAASX30.36-0.10
-0.33%
Eaton Vance Atlanta Capital SMID-Cap A
SQCBX11.19-0.04
-0.36%
X-Square Balanced Fund, LLC C
GILAX10.66-0.05
-0.47%
Lord Abbett Fundamental Equity C

CGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGC has been closely correlated with SNDL. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if CGC jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGC
1D Price
Change %
CGC100%
-15.34%
SNDL - CGC
77%
Closely correlated
+1.02%
ACB - CGC
73%
Closely correlated
-7.16%
TLRY - CGC
66%
Loosely correlated
+0.41%
OGI - CGC
65%
Loosely correlated
-0.63%
CRON - CGC
62%
Loosely correlated
-1.36%
More